lauric acid and dinoprostone

lauric acid has been researched along with dinoprostone in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
CaJacob, CA; Masters, BS; Muerhoff, AS; Ortiz de Montellano, PR; Reich, NO; Williams, DE1
Chen, J; Fu, H; Guan, X; Gui, B; Guo, Y; Hu, J; Jin, L; Li, S; Wang, J; Xu, Y; Zhang, Q; Zhang, R1

Other Studies

2 other study(ies) available for lauric acid and dinoprostone

ArticleYear
Prostaglandin and fatty acid omega- and (omega-1)-oxidation in rabbit lung. Acetylenic fatty acid mechanism-based inactivators as specific inhibitors.
    The Journal of biological chemistry, 1989, Jan-15, Volume: 264, Issue:2

    Topics: Animals; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Dinoprostone; Fatty Acids, Unsaturated; Isoenzymes; Kinetics; Lauric Acids; Lung; Microsomes; Mixed Function Oxygenases; Prostaglandins A; Rabbits

1989
Urocortin promotes the development of vasculitis in a rat model of thromboangiitis obliterans via corticotrophin-releasing factor type 1 receptors.
    British journal of pharmacology, 2009, Volume: 157, Issue:8

    Topics: Aniline Compounds; Animals; Arteritis; Blood Coagulation; Corticotropin-Releasing Hormone; Cyclooxygenase 2; Dinoprostone; Intercellular Adhesion Molecule-1; Lauric Acids; Male; Peptide Fragments; Pyrimidines; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Thromboangiitis Obliterans; Thromboxane B2; Urocortins

2009